Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery system that could save lives.

New Monash University research has revealed a concerning rise in new opioid prescriptions among younger Victorians, while ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

Opioid-related neurocognitive symptoms among patients on long-term opioid therapy were most prevalent during the course of therapy.

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

After years of struggling with alcohol dependence, Shana found a combination of treatment and counseling that works for her.

Donald Trump has imposed tariffs on Mexico, Canada, and China, citing the fentanyl crisis as a significant issue exacerbating ...

Journavx is a newly-aproved painkiller that experts say could help Long Island's opioid epidemic. NewsdayTV's Virginia Huie reports.

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

ALBANY — An investigation into a series of episodes in which state prison workers have been rushed to hospitals after ...

The story of Hamilton County is the story of much of America in 2025. Overdose deaths have fallen sharply, offering hope the ...